供精IVF不增加妊娠期高血压疾病风险:澳大利亚回顾性队列
供精组高血压疾病风险无增加(aOR 0.94;95%CI 0.73-1.21),供卵组显著增加(aOR 2.34;95%CI 1.69-3.21)。
要点
- 供精IVF不增加妊娠期高血压疾病风险(aOR 0.94;95%CI 0.73-1.21)。
- 供卵(伴伴侣精子)显著增加高血压疾病风险(aOR 2.34;95%CI 1.69-3.21)。
- 供胚组高血压风险(aOR 2.0;95%CI 1.25-3.17)未高于供卵组。
核心结论
- 供精IVF妊娠不增加妊娠期高血压疾病或FGR风险,提示暴露于新精子可能不参与子痫前期发病机制。
主要发现
- 供精组高血压疾病风险与对照组无增加(aOR 0.94;95%CI 0.73-1.21)。
- 已知产次亚组中,305例经供精受孕的多产妇因新供精者无子痫前期或妊娠期高血压风险增加(aOR 1.18;95%CI 0.69-2.04)。
- 供卵(伴伴侣精子)组高血压疾病风险显著增加(aOR 2.34;95%CI 1.69-3.21)。
- 供胚组高血压疾病风险(aOR 2.0;95%CI 1.25-3.17)未高于供卵组。
- FGR总体发生率18%,供精或供胚组无显著差异,供卵组FGR增加约1.5倍。
关键数值与推荐
- 供精组高血压疾病aOR 0.94(95%CI 0.73-1.21)。
- 供卵组高血压疾病aOR 2.34(95%CI 1.69-3.21)。
- 供胚组高血压疾病aOR 2.0(95%CI 1.25-3.17)。
- 多产妇新供精者亚组aOR 1.18(95%CI 0.69-2.04)。
- FGR总体发生率18%,供卵组增加约1.5倍。
临床怎么用
- 供精IVF妊娠的产前管理可参考一般IVF妊娠,无需因供精额外增加高血压疾病监测。
- 供卵或供胚IVF妊娠应关注妊娠期高血压疾病风险增加。
局限性
- 研究高血压疾病发生率低于预期(n=862,5.6%),与IVF已知风险增高相反,但可能在各组均匀分布,不太可能引入显著偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Does IVF using donor sperm increase the risk of hypertensive disorders of pregnancy and fetal growth restriction (FGR)? SUMMARY ANSWER: IVF conceptions arising from sperm donation are not associated with an increased risk of hypertensive disorders of pregnancy or FGR. WHAT IS KNOWN ALREADY: It has been hypothesized that the absence of prior exposure to factors within the paternal ejaculate increases the risk of preeclampsia and FGR among nulliparous women or women with a new partner-the concept of 'primipaternity'. It remains unclear which element of the ejaculate is responsible: the sperm cell or the constituents of seminal fluid. IVF pregnancies arising from donor sperm where the seminal fluid is absent provide a unique opportunity to test the theory of primipaternity and the relative contribution of the sperm cell. Pregnancies conceived via artificial reproductive technology are at increased risk of preeclampsia and FGR. STUDY DESIGN, SIZE, DURATION: Theories about the development of preeclampsia and the relative contribution of spermatic factors were explored by comparing the risk of hypertensive disorders of pregnancy and FGR among IVF pregnancies conceived with autologous gametes (own eggs and partner sperm) and those conceived with donor sperm, donor egg (and partner sperm) and donor embryo. To do this, we performed a retrospective cohort analysis of pregnancy outcomes among singleton pregnancies (n = 15 443) conceived through fertility clinics within Australia between 2009 and 2017. PARTICIPANTS/MATERIALS, SETTING, METHODS: All pregnancies resulting in a singleton pregnancy delivering after 20 weeks' gestation were included. The cohort was divided into donor sperm, donor egg and donor embryo (where both gametes came from a donor to create an embryo, or in a surrogate pregnancy) groups. We also compared the data with a control group, defined as IVF-conceived pregnancies from autologous cycles. A multivariable regression model was used to calculate an adjusted odds ratio (aOR). MAIN RESULTS AND THE ROLE OF CHANCE: The final cohort contained 1435, 578 and 239 pregnancies conceived by donor sperm, donor egg and donor embryo, respectively, and 13 191 controls. There were a very small number of women lost to follow-up (31 women; 0.2% of total cohort). Compared to control pregnancies, there was no increase in the risk of hypertensive disorders among pregnancies conceived via donor sperm (aOR 0.94; 95% CI 0.73-1.21). Subgroup analysis was performed for a cohort where parity was known (n = 4551), and of these, 305 multigravida pregnancies were conceived via donor sperm. Among this cohort, no increased risk of preeclampsia or pregnancy-induced hypertension was found (aOR 1.18; 95% CI: 0.69-2.04) as a result of primipaternity (new sperm donor).A significantly increased risk for hypertensive disorders of pregnancy was associated with the use of donor eggs (but partner sperm; aOR 2.34; 95% CI 1.69-3.21). However, the association was no greater among pregnancies conceived with donor embryos (i.e. donated egg and sperm; aOR 2.0; 95% CI 1.25-3.17) than among the donor oocyte group. The overall incidence of FGR (defined as birthweight <10th centile) was 18%. There were no significant differences observed between donor sperm, or donor embryo pregnancies; however, egg donation was associated with a 1.5-fold increase in FGR. LIMITATIONS, REASONS FOR CAUTION: This study was limited by a lower than expected rate of hypertensive disorders of pregnancy (n = 862, 5.6%), which is contrary to the well-established increased risk among women using IVF. However, this is likely to be evenly distributed across the study groups and, therefore, unlikely to have introduced significant bias. WIDER IMPLICATIONS OF THE FINDINGS: These findings suggest that exposure to new sperm may not be implicated in the pathogenesis of preeclampsia. The mechanism of increased risk seen in conceptions arising from egg or embryo donation remains unclear. Further investigation is required to elucidate these mechanisms and, ultimately, improve pregnancy outcomes following IVF. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by the Australian Commonwealth Government-Graduate Research Scheme (A.K.). Salary support was provided by the National Health and Medical Research Council of Australia (S.T.), Mercy Foundation (A.L.), and the Department of Obstetrics and Gynaecology at the University of Melbourne (R.H.). There are no competing interests.
引用
- Kennedy AL, Stern CJ, Tong S, et al. The incidence of hypertensive disorders of pregnancy following sperm donation in IVF: an Australian state-wide retrospective cohort study. Hum Reprod. 2019. PMID: 31863120. doi:10.1093/humrep/dez198
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。